Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026)
Ascend Wellness Holdings' (AAWH) quarterly Common Equity came in at -$76.6 million in Q1 2026, down 245.33% year-on-year from $52.7 million in Q1 2025, and down 64.3% quarter-over-quarter from -$46.6 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Common Equity (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Common Equity history runs 7 years deep, the most recent figure standing at -$76.6 million for Q1 2026.
- On a quarterly basis, Common Equity fell 245.33% year-over-year to -$76.6 million in Q1 2026; TTM through Mar 2026 was -$76.6 million, a 245.33% decrease from a year earlier, with the FY2025 full-year figure at -$46.6 million, down 164.93% from the prior year.
- Common Equity declined to -$76.6 million in Q1 2026 per AAWH's latest filing, from -$46.6 million in the prior quarter.
- Across five years, Common Equity topped out at $186.6 million in Q2 2022 and bottomed at -$76.6 million in Q1 2026.
- The 5-year median for Common Equity is $135.8 million (2024), against an average of $98.8 million.
- Across the five-year window, Common Equity jumped 1188.41% in 2022 and tumbled 245.33% in 2026, its largest moves.
- Year by year, Common Equity stood at $163.4 million in 2022, then decreased by 12.57% to $142.9 million in 2023, then plunged by 49.74% to $71.8 million in 2024, then slumped by 164.93% to -$46.6 million in 2025, then sank by 64.3% to -$76.6 million in 2026.
- Per Business Quant, the three latest AAWH Common Equity figures stand at -$76.6 million (Q1 2026), -$46.6 million (Q4 2025), and $8.1 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | 21.93 Bn |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 8.23 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 3.23 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 47.38 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 5.90 Bn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | 56.13 Bn |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 14.66 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 3.41 Bn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 6.50 Bn |
| 10 | Ascend Wellness Holdings | 83.00 Mn | 22.91 Mn | 44.88 Mn | -76.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -76.59 Mn |
| Dec 31, 2025 | -46.62 Mn |
| Sep 30, 2025 | 8.08 Mn |
| Jun 30, 2025 | 28.15 Mn |
| Mar 31, 2025 | 52.70 Mn |
| Dec 31, 2024 | 71.80 Mn |
| Sep 30, 2024 | 88.91 Mn |
| Jun 30, 2024 | 117.54 Mn |
| Mar 31, 2024 | 135.83 Mn |
| Dec 31, 2023 | 142.87 Mn |
| Sep 30, 2023 | 159.47 Mn |
| Jun 30, 2023 | 165.96 Mn |
| Mar 31, 2023 | 148.96 Mn |
| Dec 31, 2022 | 163.42 Mn |
| Sep 30, 2022 | 174.07 Mn |
| Jun 30, 2022 | 186.62 Mn |
| Mar 31, 2022 | 158.03 Mn |
| Dec 31, 2021 | 176.48 Mn |
| Sep 30, 2021 | 184.04 Mn |
| Jun 30, 2021 | 189.32 Mn |